Natera Inc (NTRA)
Natera Inc (NTRA) carries a ŷRobot AI score of 61 out of 100. The model's fair value estimate is $340.31, 6.6% above the last close of $319.09. The chart signal reads Hold.
| Metric | NTRA |
|---|---|
| AI score | 61 / 100 |
| Chart signal | Hold |
| Fair value estimate | $340.31 |
| Upside to fair value | 6.6% |
| Previous close | $319.09 |
| P/E | -286.06 |
| Price / sales | 15.97 |
| Market cap | $46.38B |
| EPS | -1.12 |
| Revenue growth | 34.4% |
| 1-year price change | 30.5% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, Merck & Company Inc, UnitedHealth Group Incorporated, Novartis AG ADR.
Questions about NTRA
Is NTRA overvalued or undervalued right now?
As of Nov 9, 2026, ŷRobot's fair-value model estimates Natera Inc (NTRA) at $340.31 against a last close of $319.09, implying 6.6% upside to the model's estimate.
Is NTRA's chart signal bullish or bearish?
The chart-signal model classifies NTRA as Neutral as of Nov 13, 2026, with a signal score of 0.13 on a -1 to 1 scale.
What is NTRA's ŷRobot AI score?
NTRA scores 61 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Nov 13, 2026.
Is NTRA stock expensive on P/E and P/S?
NTRA trades at -286.1 times earnings and 16.0 times sales as of Nov 13, 2026.
What does NTRA's seasonal forecast show?
ŷRobot's seasonal forecast curve for NTRA reads +1.4% at 30 days, -1.1% at 90 days, and +30.5% at one year as of Nov 13, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is NTRA growing?
Natera Inc's revenue growth is +34.4% and free-cash-flow growth is +75.3% on the latest reported figures.
NTRA chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.